Nationwide Fund Advisors’s Acorda Therapeutics, Inc. ACOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-1,218
| Closed | -$3.46M | – | 2374 |
|
|
2017
Q3 | $3.46M | Buy |
1,218
+249
| +26% | +$707K | 0.01% | 1189 |
|
|
2017
Q2 | $2.29M | Buy |
969
+66
| +7% | +$156K | 0.01% | 1367 |
|
|
2017
Q1 | $2.28M | Sell |
903
-22
| -2% | -$55.4K | 0.01% | 1337 |
|
|
2016
Q4 | $2.09M | Buy |
925
+530
| +134% | +$1.2M | 0.01% | 1393 |
|
|
2016
Q3 | $990K | Buy |
395
+71
| +22% | +$178K | ﹤0.01% | 1794 |
|
|
2016
Q2 | $993K | Buy |
324
+3
| +0.9% | +$9.19K | ﹤0.01% | 1743 |
|
|
2016
Q1 | $1.03M | Sell |
321
-4
| -1% | -$12.9K | ﹤0.01% | 1714 |
|
|
2015
Q4 | $1.67M | Buy |
325
+5
| +2% | +$25.7K | 0.01% | 1458 |
|
|
2015
Q3 | $1.02M | Sell |
320
-40
| -11% | -$127K | ﹤0.01% | 1715 |
|
|
2015
Q2 | $1.44M | Sell |
360
-110
| -23% | -$440K | 0.01% | 1642 |
|
|
2015
Q1 | $1.88M | Sell |
470
-9
| -2% | -$35.9K | 0.01% | 1525 |
|
|
2014
Q4 | $2.35M | Buy |
479
+71
| +17% | +$348K | 0.01% | 1334 |
|
|
2014
Q3 | $1.66M | Buy |
408
+1
| +0.2% | +$4.07K | 0.01% | 1542 |
|
|
2014
Q2 | $1.65M | Buy |
407
+5
| +1% | +$20.2K | 0.01% | 1587 |
|
|
2014
Q1 | $1.83M | Hold |
402
| – | – | 0.01% | 1417 |
|
|
2013
Q4 | $1.41M | Sell |
402
-7
| -2% | -$24.5K | 0.01% | 1676 |
|
|
2013
Q3 | $1.68M | Buy |
409
+12
| +3% | +$49.4K | 0.01% | 1541 |
|
|
2013
Q2 | $1.57M | Buy |
+397
| New | +$1.57M | 0.01% | 1440 |
|